Modern Methods of Drug Design and Development: Volume 690
Published on 17. October 2023
Book
Hardback
598 pages
978-0-443-15871-1 (ISBN)
Description
Modern Methods of Drug Design and Development, a volume in the Methods in Enzymology series highlights new advances in the field with this new volume presenting interesting chapters on a variety of topics, including Recombinant protein purification for structural and kinetic studies, Steady-state kinetic analysis of reversible enzyme inhibitors, Steady-State Enzyme Kinetics, Analysis of enzyme kinetic data using ICEKAT, NMR techniques in drug discovery, Dynamic simulations and pre-steady state kinetics to guide drug discovery, Design and assay of substrate-product analogues for racemases and epimerases, Sensitive high throughput methods to screen for P450 inhibition: A- MI complex forming drugs, and more.
Other chapters cover Sensitive high throughput methods to screen for P450 inhibition: B-Heme loss causing drugs, Discovery and development of inhibitors of acetyltransferase Eis to combat Mycobacterium tuberculosis, Crystallographic fragment screening in academic cancer drug discovery, Fast fragment- and compound-screening pipeline at the Swiss Light Source, Chemical biology, enzymology and drug discovery, PROTACs, Proximity-Induced Pharmacology (PROTACs), and much more.
Other chapters cover Sensitive high throughput methods to screen for P450 inhibition: B-Heme loss causing drugs, Discovery and development of inhibitors of acetyltransferase Eis to combat Mycobacterium tuberculosis, Crystallographic fragment screening in academic cancer drug discovery, Fast fragment- and compound-screening pipeline at the Swiss Light Source, Chemical biology, enzymology and drug discovery, PROTACs, Proximity-Induced Pharmacology (PROTACs), and much more.
More details
Series
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
Dimensions
Height: 229 mm
Width: 152 mm
Weight
1070 gr
ISBN-13
978-0-443-15871-1 (9780443158711)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
E-Book
10/2023
Academic Press
€142.00
Available for download
Person
Dr. Matthew Lloyd is a Senior Lecturer at Department of Pharmacy & Pharmacology, Centre for Biosensors, Bioelectronics and Biodevices (C3Bio) of University of Bath, United Kingdom. He completed his Bachelor of Science at the University of Leicester, and his Doctor of Philosophy at the University of Oxford. His research is concentrated in the areas of chemical biology, enzymology, enzyme kinetics, drug discovery and cancer research.
Content
1. Recombinant protein purification for structural and kinetic studies
Matthew Lloyd, Otsile Mojanaga and K Ravi Acharya
2. Steady-state kinetic analysis of reversible enzyme inhibitors
Matthew Lloyd
3. Steady-State Enzyme Kinetics
Bharath Srinivasan
4. Analysis of enzyme kinetic data using ICEKAT
Brian C. Smith
5. NMR techniques in drug discovery
Tim Woodman
6. Dynamic simulations and pre-steady state kinetics to guide drug discovery
Ken Johnson
7. Design and assay of substrate-product analogues for racemases and epimerases
Stephen L. Bearne
8. Sensitive high throughput methods to screen for P450 inhibition: A- MI complex forming drugs
Rheem Totah
9. Sensitive high throughput methods to screen for P450 inhibition: B-Heme loss causing drugs
Rheem Totah
10. Discovery and development of inhibitors of acetyltransferase Eis to combat Mycobacterium tuberculosis
Sylvie Garneau-Tsodikova and Oleg Tsodikov
11. Crystallographic fragment screening in academic cancer drug discovery
Jane Endicott, Martin Noble and Mathew Martin
12. Fast fragment- and compound-screening pipeline at the Swiss Light Source
Justyna A. Wojdyla, May E. Sharpe and Guenter Fritz
13. Chemical biology, enzymology and drug discovery
Kevin Dalby
14. PROTACs
Matthias Baud
15. Proximity-Induced Pharmacology (PROTACs)
Matthieu Schapira
16. Chemo-enzymatic Labelling with asparaginyl endopeptidase (AEP)
Louis Luk
17. Development of 5-Aminolevulinic Acid Prodrugs for Photodynamic Therapy and Photodiagnosis
Ian Eggleston
18. Systems biology and single cell approaches
Udo Opperman
Matthew Lloyd, Otsile Mojanaga and K Ravi Acharya
2. Steady-state kinetic analysis of reversible enzyme inhibitors
Matthew Lloyd
3. Steady-State Enzyme Kinetics
Bharath Srinivasan
4. Analysis of enzyme kinetic data using ICEKAT
Brian C. Smith
5. NMR techniques in drug discovery
Tim Woodman
6. Dynamic simulations and pre-steady state kinetics to guide drug discovery
Ken Johnson
7. Design and assay of substrate-product analogues for racemases and epimerases
Stephen L. Bearne
8. Sensitive high throughput methods to screen for P450 inhibition: A- MI complex forming drugs
Rheem Totah
9. Sensitive high throughput methods to screen for P450 inhibition: B-Heme loss causing drugs
Rheem Totah
10. Discovery and development of inhibitors of acetyltransferase Eis to combat Mycobacterium tuberculosis
Sylvie Garneau-Tsodikova and Oleg Tsodikov
11. Crystallographic fragment screening in academic cancer drug discovery
Jane Endicott, Martin Noble and Mathew Martin
12. Fast fragment- and compound-screening pipeline at the Swiss Light Source
Justyna A. Wojdyla, May E. Sharpe and Guenter Fritz
13. Chemical biology, enzymology and drug discovery
Kevin Dalby
14. PROTACs
Matthias Baud
15. Proximity-Induced Pharmacology (PROTACs)
Matthieu Schapira
16. Chemo-enzymatic Labelling with asparaginyl endopeptidase (AEP)
Louis Luk
17. Development of 5-Aminolevulinic Acid Prodrugs for Photodynamic Therapy and Photodiagnosis
Ian Eggleston
18. Systems biology and single cell approaches
Udo Opperman